'Soft' Q1 Pushes Affymetrix to Bet on Applied Markets, Acquisitions to Restore Growth

Analysts were cautious about Affy's future prospects, and one well-regarded analyst suggested the firm may become an acquisition target itself.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.